Illumina Ventures — Full Portfolio

Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps.

BiotechHealthtechMedical DevicesAustin, US

NANick Arab(Founder & CTO)Ross Johnson(Co-founder & Chief Engineer)inCBCarey-Ann Burnham(Chief Executive Officer)inTravis Davies(SVP, Operations)Kyle Fieleke(SVP, Corporate Development & Finance)David Bussian(SVP, Clinical, Regulatory & Assay Development)

Co-investorsAMAMR Action Fund

Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers.

AgTechBiotechClimate TechSt. Louis, US

Barry Goldman(Co-founder)inElizabeth Gallegos(Chief Executive Officer)inJSJerry Steiner(Executive Chair)inCWCharlie Walch(Executive Officer, Director)inGlendon Schuster(Director)

Co-investorsFIFirst In VenturesRARadicle GrowthBEBetter VenturesFAFall Line CapitalGRGrantham FoundationRARA Capital+4 more

Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.

AI & Machine LearningBiotechDigital HealthBoston, US

RVRehan Verjee(Co-Founder, Chief Executive Officer, Board Director)inSBSylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)inToni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)

Co-investors5A5AM VenturesOUOUP (Osage University Partners)LILilly Asia VenturesOSOsage University Partners

Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response.

BiotechDigital HealthMedical DevicesCambridge, US

IGIrene Ghobrial(Co-founder)inKAKenneth Anderson(Co-founder)Gad Getz(Co-founder)RSRomanos Sklavenitis-Pistofidis(Co-founder)KFKeith Flaherty(Co-founder)Brian McKernan(CEO)in

Co-investorsTHThe Engine Ventures

RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.

BiotechDeep TechHardwareBoxborough, US

Thomas O'Lenic(Executive Officer, Director)Eugene Ma(Executive Officer)Charles Marshall(Executive Officer, Director)

BoardFrank Smith(Director)inWilliam Cadogan(Director)Bryson Hollimon(Director)

Co-investorsTETechnology Venture Partners

Actym Therapeutics engineers bacteria as a delivery system for therapeutics targeting cancer and fibrotic disease.

BiotechHealthtechBerkeley, US

Christopher D Thanos(Executive Officer, Director, Promoter)Kanad Das(Director)Amit Kumar(Director, Promoter)James Huang(Director)

Adventris is a biotechnology company developing cancer immunotherapy treatments.

BiotechHealthtechBaltimore, US

JHJen Herbach(Founder)inWCWilliam Collis(Founder)inMYMark Yarchoan(Founder)

Co-investorsY Y CombinatorRERefactor Capital

Alamar Biosciences develops NULISA, an ultra-high-sensitivity, high-specificity technology for analyzing hundreds of protein biomarkers from small biofluid samples, building on the team's prior spatial genomics work (RNAscope).

BiotechDeep TechHealthtechFremont, US

YLYuling Luo(Co-founder, CEO and Chair)inSCSteve Chen(Co-founder, COO and Director)inYYYiyuan Yin(Co-founder, VP of Technology)inTWTod White(President)inJMJustin McAnear(CFO)inXMXiao-Jun Ma(CTO)

Co-investorsQIQiming Venture PartnersSASamsara BioCapital

Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.

BiotechDigital HealthMedical DevicesCambridge, US

DADAVID ARTHUR SCOTT(Executive Officer)inWINSTON XIA YAN(Executive Officer)FZFENG ZHANG(Director)ANNIE HAZLEHURST(Director)

BoardKCKEITH CRANDELL(Director)DAVID R. WALT(Director)in

Co-investorsARARCH Venture PartnersONOno Venture Investment, Inc.TCTCG CrossoverALAlly Bridge GroupJAJanus Henderson InvestorsSESection 32+3 more

Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer.

BiotechHealthtechMedical Devices

SSSid Selvaraj(Founder & Chief Operating Officer)inTWTom Willis(Chief Executive Officer)inASAnthony Schmitt(Senior Vice President, Science)inEDErin Davis(Vice President, Marketing)in

Co-investorsBEBerkeley Catalyst

Attovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options.

BiotechDigital Health

ZOZaneta Odrowaz(Founder)inTao Fu, MBA, M.S.(Founder, Chief Executive Officer, and President)Zaneta Odrowaz, Ph.D.(Chief Business Officer and Co-Founder)Petter Veiby(Chief Scientific Officer and Co-Founder)inHangjun Zhan, Ph.D.(Chief Technology Officer and Co-Founder)

Co-investorsECEcoR1 CapitalFRFrazier Life SciencesNENextech InvestSASanofi VenturesVIVida VenturesGOGoldman Sachs+1 more

Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.

AI & Machine LearningBiotechDeep Tech

Co-investorsFIFirst In VenturesHEHeran PartnersKOKorysMÉMérieux Equity Partners

Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation.

BiotechDeep Tech

CGCorey Gray(Co-founder and CEO)inMMMichael McKeown(Co-founder and Head of Research)in

Co-investorsZAZAKA VC

BiotechPittsburgh, US

Michael Hoerres(Executive Officer, Director)

BoardJames Peters(Director)Steve Grenfell(Director)Paul Schmitt(Director)Noel Doheny(Director)

CubaseBio develops spatial biology tools that enable three-dimensional analysis of biological samples at scale, for drug discovery and biological research.

BiotechDeep TechStockholm, SE

Paulius Mielinis(Founder)inTVToon Verheyen(Founder)inXiaoyan Qian(Founder)in

Co-investorsLELeksell Social VenturesNONordic Science InvestmentsVOVoima Ventures

DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability.

AI & Machine LearningBiotechDeep Tech

BSBernhard Suter(Founder)in

Co-investorsZAZAKA VC

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US

VVVictor Velculescu(Founder and Board Director)inPBPeter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)inSTSusan Tousi(Chief Executive Officer)in

Co-investorsAVAV8 VenturesFOForesite CapitalINInitiate Venture PartnersMEMenlo VenturesOPOpen Field CapitalOROrbiMed+5 more

Encoded develops gene therapies for neurological disorders through an integrated platform approach.

Biotech

STStephanie Tagliatela(Founder)in

Co-investorsARARCH Venture PartnersBIBioBritGVGV (Google Ventures)MEMenlo VenturesSOSoftBank Vision FundVEVenrock

Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.

BiotechDeveloper Tools

Co-investorsCICivilization Ventures Management, LlcCOCota CapitalSASamsara BioCapital

Fuze Health operates a unified digital healthcare platform spanning digital pharmacy (FuzeRx), clinical services such as diagnostics, screening and genetics (Fuze Services), and data and technology tools (Fuze Technologies).

AI & Machine LearningDigital HealthHealthtechSaaS

Co-investorsHLHLM Venture PartnersK2K2 HealthVenturesOLOlive Tree CapitalSOSoftBank Vision FundTOTowerBrook

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtech

MSMark Sylvester(Chief Financial Officer)inAWAndrew Warner(Vice President, Product)inMZMonica Zarb(Vice President, Business Development)inDVDurand Van Arnem(Vice President, Engineering)inAlan Rope(Medical Director)in

Co-investorsCACanaan PartnersDRDreamers VCECEcho Health VenturesGVGV (Google Ventures)KAKaiser Permanente VenturesSASamsung Catalyst Fund+5 more

Genome Medical provides telehealth-enabled genetic counseling, testing, and clinical trial access for patients with rare diseases.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsISiSelect FundCACanaan Partners

Hepta develops LiquidTransformer, an AI platform for analyzing cell-free DNA fragments in blood to detect chronic disease molecular signals.

AI & Machine LearningBiotechHealthtechSan Francisco, US

HAHamed Amini(Founder)inSDSoheil Damangir(Founder)in

Co-investorsALAlumni VenturesAMAME Cloud VenturesFEFelicis VenturesSESeaX Ventures

Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.

AI & Machine LearningBiotechDeep TechSan Diego, US

TMTom Miller(Co-Founder & CEO)inFred Manby(Co-Founder & CTO)inTMThomas Miller(Founder)inNJNeil Josephson(Chief Medical Officer)inPOPete Olson(Chief Scientific Officer)inMSMichael Secora(Chief Financial Officer and Chief Corporate Development Officer)in

Co-investorsABAbingworthASAscenta CapitalCACatalio Capital ManagementALAlumni VenturesCACatalio Capital Management, LPCOCoatue Management+4 more

Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins.

BiotechDeep TechHealthtechBaltimore, US

BLBenjamin Larman(Executive Officer, Director)inJoy M Nassif(Executive Officer, Director)in

BoardMatthew Hellauer(Director)HSHerman Scholtz(Director)inCPCaroline Popper(Director)in

Co-investorsTCTCP Venture CapitalPTPTX Capital

Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology.

AI & Machine LearningBiotechLongevityRedwood City, US

FWFelix Wong(Executive Officer, Director)inDJDaniel J. Anderson(Chief Scientific Officer)inThemasap Khan(Director)

BoardKeith Loebner(Director)

Co-investorsSUSutter Hill VenturesCICivilization Ventures Management, Llc

Kallyope is a biotechnology company founded by neuroscientists that discovers and develops novel therapeutics targeting neural networks, with a lead candidate in pivotal studies for acute migraine treatment and metabolism programs approaching clinical studies.

BiotechHealthtechNew York City, US

TMTom Maniatis(Director)Nancy Thornberry(Executive Officer, Director)inKenneth Clark(Executive Officer)

BoardTMTerry McGuire(Director)inJWJoshua Wolfe(Director)inTKTim Kutzkey(Director)in

Co-investorsDNDns CapitalLULux CapitalTHThe Column GroupPOPolaris Partners

Kodikaz develops Zip-Code, a non-viral cell-specific delivery platform for gene therapy applications, particularly focused on oncology and cancer treatments.

AI & Machine LearningBiotechMedical DevicesAtlanta, US

Anthony Johnson(Co-Founder & CEO)inDr. Leon Bernal-Mizrachi(Co-Founder, CSO)in

Co-investorsEPEpidarex CapitalGRGRA Venture

Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.

BiotechDeep TechHealthtech

Co-investors+N+ND CapitalLOLongwall Venture Partners LLPM M VenturesOMOMX VenturesARARCH Venture Partners

Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.

BiotechDeep TechMedical DevicesCambridge, GB

Co-investorsARARCH Venture PartnersPEPerscitus LLP

San Diego, US

Bob Kain(Executive Officer, Director)inDBDawn Barry(Executive Officer)inJoseph C. Beery(Executive Officer, Director)

Co-investorsARARCH Venture PartnersBABain Capital VenturesF-F-Prime CapitalOSOsage University Partners

NanoCellect develops microfluidic-based cell sorters that operate at low pressure to sort cells with high viability and reduced shear stress, aimed at scientists and researchers.

BiotechHardwareMedical Devices

CNChris Neary(CEO)in

Co-investorsVEVertical Venture PartnersWAWarburg PincusFUFusionX Ventures

NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.

AgTechAI & Machine LearningFoodTechDavis, US

KCKathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)

BoardPAPaimun Amini(Director)inJSJerry Steiner(Director)inCBCarsten Boers(Director)in

Co-investorsBEBetter Ventures Central LlcBLBlue Horizon CorporationLELever VCRHRhapsody Venture PartnersSTStray Dog Capital

Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.

AI & Machine LearningBiotechDeep Tech

ADAtray Dixit(Co-founder, CEO)inBGBill Grossman(Co-founder, Strategic Advisor)in

Co-investorsADAdverb VenturesTETenmile

Protillion Biosciences develops platform technology for antibody engineering and drug discovery.

AI & Machine LearningBiotechDeep TechCarlsbad, US

CLCurtis Layton(CEO/Co-Founder)inDWDavid Walt(Co-Founder)inWGWill Greenleaf(Co-Founder)inRHRobert Hollingsworth(Chief Scientific Officer)in

BoardSKSean Kendall(Director)inMFMalek Faham(Director)in

Co-investorsARARCH Venture Partners

Santa Clara, US

Jekwan Ryu(Executive Officer, Director)Ronald M. Cook(Director)Eric Williams(Executive Officer)Tae Hoon Nahm(Director)

BoardTom Willis(Director, Executive Officer)

BiotechGreenville, US

KWKevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)

BoardMike Dial(Director)in

Co-investorsHAHatteras Venture PartnersM M VenturesMCMC Healthcare VenturesPAPappas CapitalSVSV Health InvestorsDEDementia Discovery Fund+1 more

Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.

BiotechHealthtechNew York City, US

AYAdam Yaari(Founder/CEO)inMSMaxwell Sherman(Founder/CTO)in

Co-investorsMEMetaplanetY Y Combinator

HealthtechCambridge, US

RDRahul Dhanda(Executive Officer, Director)inJCJames Collins(Director)David Walt(Director)in

BoardIRIssi Rozen(Director)in

Co-investorsCACatalio Capital Management, LPCACatalio Capital ManagementGOGood VenturesGVGV (Google Ventures)NONorthpond VenturesNONovalis LifeSciences

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.

BiotechDeep TechHealthtechSouth San Francisco, US

KGKenneth Greenberg(Co-Founder, President & CEO)in

Co-investorsVIVida VenturesLELeaps by BayerFOFoothill VenturesMEMedical Excellence CapitalVIVivo CapitalARARCH Venture Partners+1 more

Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation.

BiotechDeep TechMedical DevicesChicago, US

Ryan Clarke(Co-Founder, Chief Scientific Officer)inNBNiko Balanis, PhD(Co-Founder, Chief Technology Officer)inBrad Merrill, PhD(Co-Founder, Head of Innovation)MMMatt MacDougall, MD, PhD(Scientific Cofounder, Immunology Physician, Stanford University)inJohn Craighead, PhD(Chief Executive Officer)

Co-investorsASAstellas Venture Management LLCDCDCVC (Data Collective)DCDCVC BioDRDraper AssociatesPOPortal Innovations

Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB

Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)

Co-investorsIQIQ CapitalCACalculusCACalculus Capital Ltd.MEMEIF Proof-of-Concept & Early Stage FundMEMercia VenturesOMOMX Ventures+1 more

Castle Biosciences is a spatial biology and AI-driven diagnostic company that analyzes tissue biopsies to diagnose and assess gastrointestinal conditions.

AI & Machine LearningBiotechDigital HealthMedical Devices